Centene Corporation (CNC)
NYSE: CNCHealth CareMedical SpecialitiesUSD
At close: Nov 20, 4:02 PM ET · Delayed 15 min
CNC stock chart
Technical analysisKey statistics
All statistics- Market cap
- $31.58B
- P/E (TTM)
- 21.92
- Forward P/E
- 11.45
- EPS (TTM)
- $2.91
- Dividend yield
- None
- 52-week range
- 31.63 – 78.08
- Day range
- 63.29 – 67.44
- Volume / Avg
- 7.01M / 5.09M
- Beta
- —
- Shares outstanding
- 495.07M
- Next earnings
- Feb 9, 2027
52-week range
CNC stock today
On Nov 20, CNC ended the session at $63.78, shedding $1.80 (2.74%), versus the S&P 500's 3.70% decline. At this level, CNC sits in the middle of its 52-week range of $31.63 to $78.08: 18.3% below the high, set on Nov 5, 2026 and 101.6% above the low. CNC is up 55.0% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 74.7%.
At 21.9x trailing earnings, Centene trades below the peer-group median of 30.1x. Its forward P/E of 11.4x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Centene's next earnings report is expected on Feb 9, 2027.
Summary generated from market data by MetaCap's automated system. Methodology
About Centene
Company profileCentene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans.
- Sector
- Health Care
- Industry
- Medical Specialities
- CEO
- Ms. Sarah M. London
- Headquarters
- Saint Louis, MO
- Employees
- 61,100
- Website
- centene.com
Financial highlights
Full financialsIn fiscal 2025, Centene generated $194.78 billion in revenue, up 19.4% from fiscal 2024, its 17th consecutive year of revenue growth. Centene reported a net loss of $6.67 billion, compared with net income of $3.31 billion a year earlier. Gross margin was 7.3% (down from 10.5%) and operating margin -3.9%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $194.78B | $163.07B | $154.00B | $144.55B | $125.98B |
| Growth | +19.44% | +5.89% | +6.54% | +14.74% | +13.38% |
| Net income | $-6.67B | $3.31B | $2.70B | $1.20B | $1.35B |
| EPS (diluted) | $-13.53 | $6.31 | $4.95 | $2.07 | $2.28 |
Analyst forecast
ForecastConsensus (21 analysts)
buy
Avg. price target
$76.11+19.33%
- Strong buy 1
- Buy 7
- Hold 12
- Sell 1
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Feb 9, 2027
- Last reported (Sep/2026)
- Oct 27, 2026
- EPS actual vs est.
- $-0.14 vs $0.07
- Surprise
- -300.00%
CNC news
All CNC news- Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana, Centene and MolinaNasdaqUNH, HUM, MOH, CI
- 5 HMO Stocks to Watch Amid Sound Membership Base, Tech InnovationNasdaqUNH, HUM, MOH, CI
- Centene: Medicare And Medicaid Noises Ahead - Multi-Year Recovery In ProgressSeeking Alpha
- Health Net Providing Special Assistance to Members and Providers Affected by MP18 Fire in HumboldtPR Newswire
- Centene: Margin Repair Is Real, But The Shares Already Price It InSeeking Alpha
- Monday's ETF with Unusual Volume: LSTNasdaqLST, NVDA, AMD, CNC
- VFLO, CNC, CI, EXPE: Large Inflows Detected at ETFNasdaqVFLO, CNC, CI, EXPE
- Centene: Why The ACA Subsidy Won't Reach 2027, And What WillSeeking Alpha
Centene peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| LHLabcorp Holdings Inc. | 367.13 | -0.47% | $29.81B | vs CNC |
| ILMNIllumina Inc. | 192.82 | -3.90% | $29.15B | vs CNC |
| DGXQuest Diagnostics Incorporated | 258.28 | -0.31% | $28.42B | vs CNC |
| NTRANatera Inc. | 273.40 | -5.70% | $39.64B | vs CNC |
| GHGuardant Health Inc. | 145.83 | +0.16% | $19.73B | vs CNC |
| HUMHumana Inc. | 390.00 | +2.63% | $46.84B | vs CNC |
| MOHMolina Healthcare Inc | 198.39 | -2.43% | $10.36B | vs CNC |
| HSICHenry Schein Inc. | 83.52 | -1.51% | $9.23B | vs CNC |
Indexes, lists and sector
Index membership
Centene stock FAQ
What is Centene's stock price today?
CNC last traded at $63.78 as of Nov 20, 4:02 PM EST, down 2.74% on the day. Prices are delayed at least 15 minutes.
Does Centene pay a dividend?
No. Centene does not currently pay a regular cash dividend.
When is Centene's next earnings date?
Centene is expected to report earnings on Tuesday, February 9, 2027.
What is CNC's P/E ratio?
CNC trades at a trailing P/E ratio of 21.92 and a forward P/E of 11.45, compared with a median of 30.1 for its closest peers.
Is Centene in the S&P 500?
Yes. Centene (CNC) is a constituent of the S&P 500 index.
Who is Centene's CEO?
Ms. Sarah M. London is the chief executive officer of Centene Corporation, which has about 61,100 employees.
Has CNC ever split its stock?
Yes. The most recent CNC stock split was a 2-for-1 split on Feb 7, 2019, one of 4 splits on record.